Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas

M. Trottier, J. Lunn, R. Butler, D. Curling, T. Turnquest, R. Royer, M. R. Akbari, T. Donenberg, Judith Hurley, S. A. Narod

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The prevalence of BRCA1 and BRCA2 mutations among unselected breast cancer patients in the Bahamas is 23%. It is beneficial to advise relatives of mutation carriers that they are candidates for genetic testing. Women who test positive are then eligible for preventive interventions, such as oophorectomy. It is not clear how often relatives of women with a mutation in the Bahamas wish to undergo genetic testing for the family mutation. Furthermore, it is not clear how best to communicate this sensitive information to relatives in order to maximize patient compliance. We offered genetic testing to 202 first-degree relatives of 58 mutation carriers. Of 159 women who were contacted by the proband or other family member, only 14 made an appointment for genetic testing (9%). In contrast, among 32 relatives who were contacted directly by the genetic counselor, 27 came for an appointment (84%). This study suggests that for recruitment of relatives in the Bahamas, direct contact by counselor is preferable to using the proband as an intermediary.

Original languageEnglish (US)
Pages (from-to)182-186
Number of pages5
JournalClinical Genetics
Volume88
Issue number2
DOIs
StatePublished - Aug 1 2015

Fingerprint

Bahamas
Genetic Testing
Mutation
Appointments and Schedules
Ovariectomy
Patient Compliance
Breast Neoplasms

Keywords

  • BRCA1
  • BRCA2
  • Breast cancer
  • Genetic counseling

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Trottier, M., Lunn, J., Butler, R., Curling, D., Turnquest, T., Royer, R., ... Narod, S. A. (2015). Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas. Clinical Genetics, 88(2), 182-186. https://doi.org/10.1111/cge.12468

Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas. / Trottier, M.; Lunn, J.; Butler, R.; Curling, D.; Turnquest, T.; Royer, R.; Akbari, M. R.; Donenberg, T.; Hurley, Judith; Narod, S. A.

In: Clinical Genetics, Vol. 88, No. 2, 01.08.2015, p. 182-186.

Research output: Contribution to journalArticle

Trottier, M, Lunn, J, Butler, R, Curling, D, Turnquest, T, Royer, R, Akbari, MR, Donenberg, T, Hurley, J & Narod, SA 2015, 'Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas', Clinical Genetics, vol. 88, no. 2, pp. 182-186. https://doi.org/10.1111/cge.12468
Trottier, M. ; Lunn, J. ; Butler, R. ; Curling, D. ; Turnquest, T. ; Royer, R. ; Akbari, M. R. ; Donenberg, T. ; Hurley, Judith ; Narod, S. A. / Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas. In: Clinical Genetics. 2015 ; Vol. 88, No. 2. pp. 182-186.
@article{a6a07493728f4b8ebd723a1d31080e12,
title = "Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas",
abstract = "The prevalence of BRCA1 and BRCA2 mutations among unselected breast cancer patients in the Bahamas is 23{\%}. It is beneficial to advise relatives of mutation carriers that they are candidates for genetic testing. Women who test positive are then eligible for preventive interventions, such as oophorectomy. It is not clear how often relatives of women with a mutation in the Bahamas wish to undergo genetic testing for the family mutation. Furthermore, it is not clear how best to communicate this sensitive information to relatives in order to maximize patient compliance. We offered genetic testing to 202 first-degree relatives of 58 mutation carriers. Of 159 women who were contacted by the proband or other family member, only 14 made an appointment for genetic testing (9{\%}). In contrast, among 32 relatives who were contacted directly by the genetic counselor, 27 came for an appointment (84{\%}). This study suggests that for recruitment of relatives in the Bahamas, direct contact by counselor is preferable to using the proband as an intermediary.",
keywords = "BRCA1, BRCA2, Breast cancer, Genetic counseling",
author = "M. Trottier and J. Lunn and R. Butler and D. Curling and T. Turnquest and R. Royer and Akbari, {M. R.} and T. Donenberg and Judith Hurley and Narod, {S. A.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/cge.12468",
language = "English (US)",
volume = "88",
pages = "182--186",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas

AU - Trottier, M.

AU - Lunn, J.

AU - Butler, R.

AU - Curling, D.

AU - Turnquest, T.

AU - Royer, R.

AU - Akbari, M. R.

AU - Donenberg, T.

AU - Hurley, Judith

AU - Narod, S. A.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The prevalence of BRCA1 and BRCA2 mutations among unselected breast cancer patients in the Bahamas is 23%. It is beneficial to advise relatives of mutation carriers that they are candidates for genetic testing. Women who test positive are then eligible for preventive interventions, such as oophorectomy. It is not clear how often relatives of women with a mutation in the Bahamas wish to undergo genetic testing for the family mutation. Furthermore, it is not clear how best to communicate this sensitive information to relatives in order to maximize patient compliance. We offered genetic testing to 202 first-degree relatives of 58 mutation carriers. Of 159 women who were contacted by the proband or other family member, only 14 made an appointment for genetic testing (9%). In contrast, among 32 relatives who were contacted directly by the genetic counselor, 27 came for an appointment (84%). This study suggests that for recruitment of relatives in the Bahamas, direct contact by counselor is preferable to using the proband as an intermediary.

AB - The prevalence of BRCA1 and BRCA2 mutations among unselected breast cancer patients in the Bahamas is 23%. It is beneficial to advise relatives of mutation carriers that they are candidates for genetic testing. Women who test positive are then eligible for preventive interventions, such as oophorectomy. It is not clear how often relatives of women with a mutation in the Bahamas wish to undergo genetic testing for the family mutation. Furthermore, it is not clear how best to communicate this sensitive information to relatives in order to maximize patient compliance. We offered genetic testing to 202 first-degree relatives of 58 mutation carriers. Of 159 women who were contacted by the proband or other family member, only 14 made an appointment for genetic testing (9%). In contrast, among 32 relatives who were contacted directly by the genetic counselor, 27 came for an appointment (84%). This study suggests that for recruitment of relatives in the Bahamas, direct contact by counselor is preferable to using the proband as an intermediary.

KW - BRCA1

KW - BRCA2

KW - Breast cancer

KW - Genetic counseling

UR - http://www.scopus.com/inward/record.url?scp=84935070547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935070547&partnerID=8YFLogxK

U2 - 10.1111/cge.12468

DO - 10.1111/cge.12468

M3 - Article

VL - 88

SP - 182

EP - 186

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 2

ER -